Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Acta Neurochirurgica
Published in: Acta Neurochirurgica 2/2013

01-02-2013 | Clinical Article - Functional

The influence of intraoperative microelectrode recordings and clinical testing on the location of final stimulation sites in deep brain stimulation for Parkinson’s disease

Authors: Juergen Ralf Schlaier, Christine Habermeyer, Annette Janzen, Claudia Fellner, Andreas Hochreiter, Martin Proescholdt, Alexander Brawanski, Max Lange

Published in: Acta Neurochirurgica | Issue 2/2013

Login to get access

Abstract

Background

The goal of our study was to investigate the influence of intraoperative microelectrode recordings and clinical testing on the location of the final stimulation site in deep brain stimulation in Parkinson’s disease.

Methods

In 22 patients with Parkinson’s disease we compared magnetic resonance imaging (MRI)-based and atlas-based targets with the adjusted stimulation sites after intraoperative, multitrack microelectrode recording (MER) and intraoperative and postoperative clinical testing. The investigation included 176 target/stimulation sites in 44 subthalamic nuclei (STNs), which were related to a standardised three-dimensional, MRI-defined STN.

Results

Atlas-based targets were positioned more superior and more medial than the MRI-based targets, which were located in the centre of the MRI-STN. The optimal stimulation sites, found intraoperatively after MER and clinical testing, were located more lateral and slightly more superior than both planned targets. In the majority of the cases the location of the active contact was the most superior and most lateral of all target sites. The differences in the distributions of those four targets reached statistical significance. However, final active contacts were distributed throughout the MRI-defined STN and its immediate surroundings.

Conclusions

The adoption of microelectrode recordings and extensive clinical testing allows the adjustment of anatomical targeting even to unexpected stimulation sites in and around the MRI-defined STN.
Literature
1.
Deep Brain Stimulation Study Group (2001) Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 345:956–963CrossRef
2.
Bejjani BP, Dormont D, Pidoux B, Yelnik J, Damier P, Arnulf I, Bonnet AM, Marsault C, Agid Y, Philippon J, Cornu P (2000) Bilateral subthalamic stimulation for Parkinson’s disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg 92:615–625PubMedCrossRef
3.
Benabid AL, Koudsie A, Fraix V, Benazzouz A, Chabardes S, LeBas JF, Polak P (2001) High-frequency stimulation of the subthalamic nucleus in advanced Parkinson’s disease: an 8-year experience. J Neurosurg 94:376A
4.
Benabid AL, Krack PP, Benazzouz A, Limousin P, Koudsie A, Pollak P (2000) Deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: methodologic aspects and clinical criteria. Neurology 55:S40–S44PubMed
5.
Binder DK, Rau GM, Starr PA (2005) Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery 56:722–732, discussion 722–732PubMedCrossRef
6.
Caire F, Ouchchane L, Coste J, Gabrillargues J, Derost P, Ulla M, Durif F, Lemaire JJ (2009) Subthalamic nucleus location: relationships between stereotactic AC-PC-based diagrams and MRI anatomy-based contours. Stereotact Funct Neurosurg 87:337–347PubMedCrossRef
7.
Danish SF, Jaggi JL, Moyer JT, Finkel L, Baltuch GH (2006) Conventional MRI is inadequate to delineate the relationship between the red nucleus and subthalamic nucleus in Parkinson’s disease. Stereotact Funct Neurosurg 84:12–18PubMedCrossRef
8.
Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355:896–908PubMedCrossRef
9.
Dormont D, Ricciardi KG, Tande D, Parain K, Menuel C, Galanaud D, Navarro S, Cornu P, Agid Y, Yelnik J (2004) Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data. AJNR Am J Neuroradiol 25:1516–1523PubMed
10.
Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ Jr, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ (2010) Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med 362:2077–2091PubMedCrossRef
11.
Foltynie T, Zrinzo L, Martinez-Torres I, Tripoliti E, Petersen E, Holl E, Aviles-Olmos I, Jahanshahi M, Hariz M, Limousin P (2011) MRI-guided STN DBS in Parkinson’s disease without microelectrode recording: efficacy and safety. J Neurol Neurosurg Psychiatry 82:358–363PubMedCrossRef
12.
Gorgulho A, De Salles AA, Frighetto L, Behnke E (2005) Incidence of hemorrhage associated with electrophysiological studies performed using macroelectrodes and microelectrodes in functional neurosurgery. J Neurosurg 102:888–896PubMedCrossRef
13.
Guehl D, Edwards R, Cuny E, Burbaud P, Rougier A, Modolo J, Beuter A (2007) Statistical determination of the optimal subthalamic nucleus stimulation site in patients with Parkinson disease. J Neurosurg 106:101–110PubMedCrossRef
14.
Hamani C, Saint-Cyr JA, Fraser J, Kaplitt M, Lozano AM (2004) The subthalamic nucleus in the context of movement disorders. Brain 127:4–20PubMedCrossRef
15.
Hariz MI (2002) Safety and risk of microelectrode recording in surgery for movement disorders. Stereotact Funct Neurosurg 78:146–157PubMedCrossRef
16.
Lopiano L, Rizzone M, Perozzo P, Tavella A, Torre E, Lanotte M, Bergamasco B (2001) Deep brain stimulation of the subthalamic nucleus: selection of patients and clinical results. Neurol Sci 22:67–68PubMedCrossRef
17.
Maldonado IL, Roujeau T, Cif L, Gonzalez V, El-Fertit H, Vasques X, Bonafe A, Coubes P (2009) Magnetic resonance-based deep brain stimulation technique: a series of 478 consecutive implanted electrodes with no perioperative intracerebral hemorrhage. Neurosurgery 65:196–201, discussion 201–192PubMedCrossRef
18.
Okun MS, Vitek JL (2004) Lesion therapy for Parkinson’s disease and other movement disorders: update and controversies. Mov Disord 19:375–389PubMedCrossRef
19.
Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20:128–154PubMedCrossRef
20.
Patel NK, Khan S, Gill SS (2008) Comparison of atlas- and magnetic-resonance-imaging-based stereotactic targeting of the subthalamic nucleus in the surgical treatment of Parkinson’s disease. Stereotact Funct Neurosurg 86:153–161PubMedCrossRef
21.
Richter EO, Hoque T, Halliday W, Lozano AM, Saint-Cyr JA (2004) Determining the position and size of the subthalamic nucleus based on magnetic resonance imaging results in patients with advanced Parkinson disease. J Neurosurg 100:541–546PubMedCrossRef
22.
Schlaier J, Schoedel P, Lange M, Winkler J, Warnat J, Dorenbeck U, Brawanski A (2005) Reliability of atlas-derived coordinates in deep brain stimulation. Acta Neurochir (Wien) 147:1175–1180, discussion 1180CrossRef
23.
Schlaier JR, Habermeyer C, Warnat J, Lange M, Janzen A, Hochreiter A, Proescholdt M, Brawanski A, Fellner C (2011) Discrepancies between the MRI- and the electrophysiologically defined subthalamic nucleus. Acta Neurochir (Wien) 153:2307-2318CrossRef
24.
Starr PA, Christine CW, Theodosopoulos PV, Lindsey N, Byrd D, Mosley A, Marks WJ Jr (2002) Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg 97:370–387PubMedCrossRef
25.
Starr PA, Martin AJ, Ostrem JL, Talke P, Levesque N, Larson PS (2010) Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy. J Neurosurg 112:479–490PubMedCrossRef
26.
Voges J, Hilker R, Botzel K, Kiening KL, Kloss M, Kupsch A, Schnitzler A, Schneider GH, Steude U, Deuschl G, Pinsker MO (2007) Thirty days complication rate following surgery performed for deep-brain-stimulation. Mov Disord 22:1486–1489PubMedCrossRef
27.
Voges J, Volkmann J, Allert N, Lehrke R, Koulousakis A, Freund HJ, Sturm V (2002) Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. J Neurosurg 96:269–279PubMedCrossRef
28.
Wodarg F, Herzog J, Reese R, Falk D, Pinsker MO, Steigerwald F, Jansen O, Deuschl G, Mehdorn HM, Volkmann J (2012) Stimulation site within the MRI-defined STN predicts postoperative motor outcome. Mov Disord 27:874–879PubMedCrossRef
29.
Zhu XL, Hamel W, Schrader B, Weinert D, Hedderich J, Herzog J, Volkmann J, Deuschl G, Muller D, Mehdorn HM (2002) Magnetic resonance imaging-based morphometry and landmark correlation of basal ganglia nuclei. Acta Neurochir (Wien) 144:959–969, discussion 968–959CrossRef
Metadata
Title
The influence of intraoperative microelectrode recordings and clinical testing on the location of final stimulation sites in deep brain stimulation for Parkinson’s disease
Authors
Juergen Ralf Schlaier
Christine Habermeyer
Annette Janzen
Claudia Fellner
Andreas Hochreiter
Martin Proescholdt
Alexander Brawanski
Max Lange
Publication date
01-02-2013
Publisher
Springer Vienna
Published in
Acta Neurochirurgica / Issue 2/2013
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-012-1592-x

Other articles of this Issue 2/2013

Acta Neurochirurgica 2/2013 Go to the issue

Technical Note - Neurosurgical Techniques

Hollow screws: a diagnostic tool for intracranial empyema

Clinical Article - Vascular

Treatment for brain arteriovenous malformation in the 1998–2011 period and review of the literature

Letter to the editor - Vascular

Unusual angiographic images of unruptured, large, kissing middle cerebral artery aneurysms

Letter to the editor - Spine

Foreign body reaction to hydroxyapatite after anterior cervical discectomy with fusion

Clinical Article - Spine

Subaxial cervical juxtafacet cysts: single institution surgical experience and literature review

Letter to the Editor

Answer: “Minimally invasive decompression of chronic subdural haematomas using hollow screws: efficacy and safety in a consecutive series of 320 cases”